Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Current Leases (2019 - 2025)

Pediatrix Medical (MD) has disclosed Current Leases for 14 consecutive years, with $11.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Leases fell 8.76% to $11.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.6 million, a 8.76% decrease, with the full-year FY2025 number at $11.6 million, down 8.76% from a year prior.
  • Current Leases was $11.6 million for Q4 2025 at Pediatrix Medical, down from $12.2 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $22.7 million in Q3 2022 to a low of $2.3 million in Q2 2021.
  • A 5-year average of $14.9 million and a median of $17.9 million in 2024 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: crashed 89.4% in 2021, then skyrocketed 785.96% in 2022.
  • Pediatrix Medical's Current Leases stood at $19.7 million in 2021, then rose by 9.68% to $21.6 million in 2022, then fell by 2.38% to $21.1 million in 2023, then crashed by 39.72% to $12.7 million in 2024, then dropped by 8.76% to $11.6 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Current Leases are $11.6 million (Q4 2025), $12.2 million (Q3 2025), and $12.0 million (Q2 2025).